Shirish S. Huprikar
- ASSOCIATE PROFESSOR Medicine, Infectious Diseases
B.A., Northwestern University
- Dr. Huprikar sees patients with or at risk for HIV/Aids in the Jack Martin Fund Clinic located in the Center for Ambulatory Medicine, 17 East 102nd Street, 3rd floor, New York, NY 10029. Insurances accepted are Medicaid, Medicare and ADAP.
Shirish Huprikar, M.D. is an Associate Professor in the Department of Medicine.
As Director of the Transplant Infectious Diseases Program since 2003, Dr. Huprikar has developed a program dedicated to the prevention and management of infectious diseases in solid organ and bone marrow transplant recipients as well as other immunocompromised hosts. Under his direction the program provides the following services: collaboration with each individual transplant program to provide excellent clinical care in both the inpatient and outpatient setting; educational support for each individual transplant program to ensure that the clinical practices meet the standard of care; expertise to develop guidelines for the prevention and management of infections for each individual transplant program; innovative research initiatives that advance the field and improve the care of our patients.
As Associate Program Director of the Infectious Diseases Fellowship Program since 2001 and as Program Director since 2008, Dr. Huprikar has established Mount Sinai's program as one of the most competitive in the nation. The program offers a most diverse clinical experience combined with a comprehensive educational curriculum and mentored research curriculum.
Dr. Huprikar has received numerous teaching awards from the Department of Medicine and was recognized by the institution for his clinical work with the Solomon Silver Award in Clinical Medicine. He has mentored and trained over 20 infectious diseases fellows, internal medicine residents and medical students.
Dr. Huprikar's research interests include solid organ transplantation in HIV-infected patients, invasive fungal infections, the prevention and management of post-transplant CMV infections, and resistant bacterial pathogens.
Dr. Huprikar received his M.D. from Northwestern University and then trained in medicine and infectious diseases at The Mount Sinai Medical Center before joining the faculty in 2001.
Solomon Silver Award in Clinical Medicine
Mount Sinai School of Medicine
Research SummaryDr. Huprikar's research interest include solid organ transplantation in HIV-infected patients, the prevention and management of post-transplant CMV and fungal infections and resistant bacterial pathogens in transplant candidates and recipients.
Kubak BM, Huprikar SS. Emerging and Rare fungal infections in solid organ transplant recipients. AM J Transplant 2009 Dec; 9(4): S208-S226.
Huprikar S. RE: Effect of Prophylaxis on Fungal Infection and Costs for High-Risk Liver Transplant Recipients (letter). Liver Transplantation 2008 May; 14(5): 709.
Trindade AJ, Huysman A, Huprikar SS, Kim MK. A Case Study and Review of Pancreatitis in the AIDS Population. Dig Dis Sci 2008 Feb 21; Epub ahead of print.
Patel G, Arvelakis A, Sauther B, Gondolesi G, Caplivski D, Huprikar S. Case Report: Strongyloides Hyperinfection Syndrome after Intestinal Transplantation. Transpl Infect Dis 2008 Apr; 10(2): 137-141.
Huprikar S. Update in Infectious Diseases in Liver Transplant Recipients. Clin Liver Dis 2007 May; 11: 337-354.
Linden E, Restrepo D, Murphy B, Huprikar SS. Aspergillus Infection Limited to Renal Allograft: Case Report and Review of Literature. Transpl Infect Dis 2006 September; 8(3): 177-181.
Restrepo D, Huprikar SS, Vanhorn K, Bottone EJ. O1 and non-O1 Vibrio cholerae bacteremia produced by hemolytic strains. Diagn Microbiol Infect Dis 2006 February; 54(2): 145-148.
Caplivski D, Salama C, Huprikar SS, Bottone EJ. Disseminated histoplasmosis in five immunosuppressed patients: clinical, diagnostic, and therapeutic perspectives. Rev Med Micro 2005; 16: 1-7.
Dorell K, Cohen MA, Jones M, Huprikar SS, Gorman JM. Citalopram-induced diplopia. Psychosomatics 2005; 46: 91-93.
Sayegh SE, Keller MJ, Huprikar SS, Murphy B. Solid organ transplantation in HIV-infected recipients. Pediatr Transplant 2004 June; 8(3): 214-221.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Huprikar during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Oxford Immunotec, Inc.; Sunshine Heart, Inc.
Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Annenberg Building Floor 23rd Floor Room Room 201
1468 Madison Avenue
New York, NY 10029